Aldehyde dehydrogenase 2 protects cardiomyocytes against lipotoxicity via the AKT/glycogen synthase kinase 3 beta pathways
- 21 February 2020
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 525 (2), 360-365
- https://doi.org/10.1016/j.bbrc.2020.02.096
Abstract
No abstract availableKeywords
Funding Information
- China Postdoctoral Science Foundation (2017M612293)
- National Natural Science Foundation of China (81400282)
This publication has 32 references indexed in Scilit:
- Lipotoxicity and the Development of Heart Failure: Moving from Mouse to ManCell Metabolism, 2010
- Cellular Stress Responses: Cell Survival and Cell DeathInternational Journal of Cell Biology, 2010
- Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variantNature Structural & Molecular Biology, 2010
- Myocardial Fatty Acid Metabolism in Health and DiseasePhysiological Reviews, 2010
- No death without life: vital functions of apoptotic effectorsCell Death & Differentiation, 2008
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005
- Oxidized LDL induces ventricular myocyte damage and abnormal electrical activity?role of lipid hydroperoxidesCardiovascular Research, 2005
- The Bcl2 family: regulators of the cellular life-or-death switchNature Reviews Cancer, 2002
- Oxidized LDL and HDL: antagonists in atherothrombosisThe FASEB Journal, 2001
- Bax-induced Caspase Activation and Apoptosis via Cytochromec Release from Mitochondria Is Inhibitable by Bcl-xLOnline Journal of Public Health Informatics, 1999